Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia

Pharmacology, Biochemistry, and Behavior
N R Swerdlow, M A Geyer

Abstract

Prepulse inhibition (PPI) of the acoustic startle response is a measure of sensorimotor gating that is impaired in both schizophrenic patients and in rats treated with dopamine agonists. The disruption of PPI by the dopamine agonist apomorphine (APO) is reversed by antipsychotic agents, including the atypical antipsychotic clozapine. Across a range of compounds, the ability of antipsychotics to restore PPI in APO-treated rats correlates significantly with their clinical potency. Since few animal models predict antipsychotic potency for clozapine, we further characterized the effects of clozapine and the typical antipsychotic haloperidol on APO-disrupted and baseline PPI in rats. The APO-induced disruption of PPI caused by intense (15 dB over background) prepulses was reversed in a dose-dependent manner by both clozapine and haloperidol. When weak (1-5 dB over background) prepulses were used, clozapine and haloperidol increased baseline PPI in control animals. Both APO-disrupted and baseline PPI may be useful in screening both typical and atypical antipsychotic agents.

References

Mar 1, 1992·Archives of General Psychiatry·D L BraffM A Geyer
Jan 1, 1991·Progress in Neuro-psychopharmacology & Biological Psychiatry·N R SwerdlowM A Geyer
Jan 1, 1987·Psychopharmacology·I Weiner, J Feldon
Jan 1, 1988·Psychopharmacology·R S MansbachD L Braff
Feb 1, 1968·The Journal of the Acoustical Society of America·H S Hoffman, J L Searle
Jan 1, 1961·The British Journal of Medical Psychology·A MCGHIE, J CHAPMAN

❮ Previous
Next ❯

Citations

Mar 12, 2008·Psychopharmacology·Marco BortolatoRoberto Stancampiano
Aug 1, 1996·Biological Psychiatry·H T NagamotoR Freedman
Dec 1, 1994·Pharmacology, Biochemistry, and Behavior·P CurzonM W Decker
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Shitij KapurMing Li
Jun 16, 2005·Pharmacology, Biochemistry, and Behavior·Andrea GogosMaarten van den Buuse
Mar 18, 2000·European Journal of Pharmacology·C K Jones, H E Shannon
Oct 24, 2001·European Journal of Pharmacology·M Van den Buuse, N Eikelis
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·T BastI M White
Aug 18, 2001·Pharmacology, Biochemistry, and Behavior·R S MansbachS H Zorn
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·B PouzetJ Arnt
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·B PouzetJ Arnt
Nov 5, 1997·Pharmacology, Biochemistry, and Behavior·D Feifel, K L Minor
Aug 26, 1998·Pharmacology, Biochemistry, and Behavior·S HartN R Swerdlow
Nov 14, 1997·Neuroscience and Biobehavioral Reviews·S A JosselynR J Beninger
Aug 6, 2003·Behavioural Brain Research·Jian Hong WangMaarten van den Buuse
Apr 9, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·P Curzon, M W Decker
Aug 27, 1999·Progress in Neurobiology·M Koch
Aug 8, 1998·Epilepsy Research·H R PouretemadP B Fenwick
Sep 6, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Femke T A PijlmanJan M van Ree
Apr 23, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Letisha R WyattDaryl L Davies
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nobuaki EgashiraMichihiro Fujiwara
Jan 6, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Min ZhangLynne E Rueter
Feb 17, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Neal R SwerdlowJody M Shoemaker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here